SPDR S&P Biotech Etf (Xbi) Stake Lessened by Assetmark Inc.


Assetmark Inc. lowered its stake in shares of SPDR S&P Biotech ETF by 34.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission . The fund owned 830,727 shares of the exchange traded fund's stock after selling 433,286 shares during the period.



from Biotech News